Literature DB >> 10539863

Mouse models of Chlamydia pneumoniae infection and atherosclerosis.

L A Campbell1, C c Kuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10539863     DOI： 10.1016/s0002-8703(99)70290-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  6 in total

1.  Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.

Authors:  J B Mahony; S Chong; B K Coombes; M Smieja; A Petrich
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Heat-inactivated C. pneumoniae organisms are not atherogenic.

Authors:  Jyotika Sharma; Yuhong Niu; Jianbo Ge; Grant N Pierce; Guangming Zhong
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

3.  Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.

Authors:  L Liu; H Hu; H Ji; A D Murdin; G N Pierce; G Zhong
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

4.  Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.

Authors:  G Arno; J C Kaski; D A Smith; J P Akiyu; S E Hughes; C Baboonian
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

5.  Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages.

Authors:  Shinn-Jong Jiang; Cho-Chou Kuo; Mark W Berry; Amy W Lee; Lee Ann Campbell
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

Review 6.  Immunopathogenesis of Chlamydial Infections.

Authors:  Ashlesh K Murthy; Weidang Li; Kyle H Ramsey
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.